StockNews.AI
FBIO
StockNews.AI
12 hrs

Fortress Biotech Investigated by the Portnoy Law Firm

1. Portnoy Law Firm investigates Fortress Biotech for possible securities fraud. 2. FDA issued Complete Response Letter for CUTX-101 due to manufacturing deficiencies. 3. Stock price declined following negative news regarding CUTX-101's NDA. 4. Law firm aims to represent investors for potential claims against the company. 5. Prior successes include recovering $5.5 billion for aggrieved investors.

3m saved
Insight
Article

FAQ

Why Bearish?

The issuance of a CRL can severely dent investor confidence, historically correlating with stock declines.

How important is it?

The investigation can lead to significant legal and financial consequences for FBIO, affecting stock prices.

Why Short Term?

Immediate investor reaction due to negative FDA news will likely influence stock in the near term.

Related Companies

CYRXVRTXAMGN
LOS ANGELES, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fortress Biotech Inc., ("Slide" or the "Company") (NASDAQ: FBIO) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.  Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/fortress-biotech-inc. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses. On October 1, 2025, Fortress and its subsidiary, Cyprium Therapeutics, Inc., announced that the FDA issued a Complete Response Letter (“CRL”) relating to the New Drug Application (“NDA”) for CUTX-101 and that the “CRL noted cGMP deficiencies had been observed at the facility where CUTX-101 is manufactured.”  Following this news, the price of the Company’s stock dropped. The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes. Lesley F. Portnoy, Esq.Admitted CA, NY and TX Barlesley@portnoylaw.com310-692-8883www.portnoylaw.com Attorney Advertising

Related News